Slingshot members are tracking this event:

Phase 3 presentation of Actinium Pharma's(ATNM) Iomab-B in Hematopoietic Stem Cells Transplantation expected at ASCO

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ATNM Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Iomab-b, Asco 2019, Hematopoietic Stem Cell Transplantation